MWM
INSM icon

Mascoma Wealth Management’s Insmed INSM Stock Holding History

Mascoma Wealth Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107 Buy
+1
New +$121 ﹤0.01% 599

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Mascoma Wealth Management's INSM Position: Q2 2026 in Review

Mascoma Wealth Management opened a new position in Insmed (INSM) in Q2 2026: 1 share worth $107. The stake represents ﹤0.01% of the portfolio and ranks #599 among its holdings.

663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Mascoma Wealth Management held 1 share of Insmed worth $107 as of Q2 2026.
  • Insmed was a new Mascoma Wealth Management position in Q2 2026.
  • Insmed made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #599 holding.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.